CH504436A - Verfahren zur Herstellung von Estern - Google Patents
Verfahren zur Herstellung von EsternInfo
- Publication number
- CH504436A CH504436A CH343170A CH343170A CH504436A CH 504436 A CH504436 A CH 504436A CH 343170 A CH343170 A CH 343170A CH 343170 A CH343170 A CH 343170A CH 504436 A CH504436 A CH 504436A
- Authority
- CH
- Switzerland
- Prior art keywords
- carbon atoms
- alkyl
- radical
- alk
- pyridine
- Prior art date
Links
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 title abstract 4
- 206010061218 Inflammation Diseases 0.000 title abstract 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 title abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 16
- 150000003839 salts Chemical class 0.000 claims abstract description 5
- 238000000034 method Methods 0.000 claims description 10
- 150000003222 pyridines Chemical class 0.000 claims description 7
- 229910052739 hydrogen Inorganic materials 0.000 claims description 6
- 239000001257 hydrogen Substances 0.000 claims description 6
- 125000005843 halogen group Chemical group 0.000 claims description 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 5
- 150000002148 esters Chemical class 0.000 claims description 4
- 150000001339 alkali metal compounds Chemical class 0.000 claims description 3
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical compound [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 230000029936 alkylation Effects 0.000 claims 2
- 238000005804 alkylation reaction Methods 0.000 claims 2
- 150000001350 alkyl halides Chemical class 0.000 claims 1
- 239000003960 organic solvent Substances 0.000 claims 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 4
- 102000008946 Fibrinogen Human genes 0.000 abstract description 2
- 108010049003 Fibrinogen Proteins 0.000 abstract description 2
- 230000001754 anti-pyretic effect Effects 0.000 abstract description 2
- 239000008280 blood Substances 0.000 abstract description 2
- 210000004369 blood Anatomy 0.000 abstract description 2
- 235000012000 cholesterol Nutrition 0.000 abstract description 2
- 229940012952 fibrinogen Drugs 0.000 abstract description 2
- 150000003626 triacylglycerols Chemical class 0.000 abstract description 2
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 abstract 2
- 125000006274 (C1-C3)alkoxy group Chemical group 0.000 abstract 1
- ZRIRCVPXOVMZRG-UHFFFAOYSA-N 2-[6-(4-chlorophenyl)-2-methylpyridin-3-yl]acetic acid Chemical compound C1=C(CC(O)=O)C(C)=NC(C=2C=CC(Cl)=CC=2)=C1 ZRIRCVPXOVMZRG-UHFFFAOYSA-N 0.000 abstract 1
- 229940035676 analgesics Drugs 0.000 abstract 1
- 239000000730 antalgic agent Substances 0.000 abstract 1
- 239000002221 antipyretic Substances 0.000 abstract 1
- 229940125716 antipyretic agent Drugs 0.000 abstract 1
- -1 alkoxy radical Chemical class 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- 150000003254 radicals Chemical class 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 3
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- LSKBPEPPOBUWNF-UHFFFAOYSA-N dimethyl 2-[5-(4-chlorophenyl)-6-methoxypyridin-2-yl]propanedioate Chemical compound ClC1=CC=C(C=C1)C=1C(=NC(=CC1)C(C(=O)OC)C(=O)OC)OC LSKBPEPPOBUWNF-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 229910000104 sodium hydride Inorganic materials 0.000 description 2
- 239000012312 sodium hydride Substances 0.000 description 2
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical class Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- QUPDWYMUPZLYJZ-UHFFFAOYSA-N ethyl Chemical compound C[CH2] QUPDWYMUPZLYJZ-UHFFFAOYSA-N 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 150000002367 halogens Chemical group 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- ZIYVHBGGAOATLY-UHFFFAOYSA-N methylmalonic acid Chemical compound OC(=O)C(C)C(O)=O ZIYVHBGGAOATLY-UHFFFAOYSA-N 0.000 description 1
- GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical compound [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/26—Radicals substituted by halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/56—Amides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/57—Nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
Verfahren zur Herstellung von Estern Die Erfindung betrifft ein Verfahren zur Herstellung von neuen Estern, die entzündungshemmende, schmerz- stillende und antipyretische Eigenschaften haben und die Konzentration von Fibrinogen sowie von Cholesterin und/oder Triglyceriden im Blut herabzusetzen vermögen und somit für die Behandlung oder Prophylaxe von Koronararterienkrankheit und Atherosklerose geeignet sind.
Gemäss der Erfindung werden Ester der Formel I
EMI0001.0005
in welcher X Wasserstoff, einen Alkyl- oder Alkoxyrest mit höchstens 3 C-Atomen oder ein Halogenatom, Y einen gegebenenfalls durch ein oder zwei Halogenatome substituierten Phenylrest, RÚ Wasserstoff, einen Alkyl rest mit höchstens 3 C-Atomen oder einen Alkoxycarbo- nylrest mit höchstens 6 C-Atomen und R2 einen Alkyl rest mit höchstens 5 C-Atomen bedeuten, Alk für einen Alkylrest mit höchstens 3 C-Atomen steht und die Reste Y und - C(Alk)RÚ - COORê nicht an benachbarte C- Atome des Pyridinkerns gebunden sind, hergestellt.
Das erfindungsgemässe Verfahren besteht darin, dass man ein Pyridinderivat der Formel II
EMI0001.0014
oder eine Alkalimetallverbindung davon, in welcher X, Y, RÚ und R2 die obige Bedeutung besitzen und die Reste Y und - C(Alk)RÚ-COORê nicht an benachbarte C-Atome gebunden sind, entsprechend alkyliert.
Zweckmässig kann X z.B. ein Wasserstoffatom, ein Methyl- oder Methoxyradikal oder ein Chlor- oder Bromatom. darstellen.
Als Beispiele für das oder die Halogenatome, die gegebenenfalls im Y-Radikal vorhanden sind, kann man Fluor-, Chlor- und Bromatome erwähnen. Die Verbin dungen, bei denen das Y-Radikal einen oder zwei Halo- gensubstituenten enthält, stellen bevorzugte Verbindun gen dar, weil sie im allgemeinen aktiver sind, als die entsprechenden urisubstituierten Phenylderivate.
RÚ kann Wasserstoff oder ein Methyl-, Methoxy- carbonyl- oder Äthoxycarbonylrest sein. Das Symbol Alk kann z.B. das Methyl- oder Athylradikal darstellen.
Als Salze der Pyridinderivate sind insbesondere die pharmazeutisch zulässigen Säureadditionssalze, wie z.B. Hydrochloride, Hydrobromide, Sulfate oder Phosphate, geeignet.
Die als Ausgangsprodukte verwendeten Pyridinderi- vate der Formel II können nach an sich bekannten Methoden hergestellt werden. Die Erfindung ist im folgenden anhand von Ausführungsbeispielen näher erläutert.
<I>Beispiel I</I> Es wurden 3,0g Dimethyl-3-(4-chlorphenyl)-2-me- thoxypyrid-6-ylmalonat 1 Stunde mit Natriumhydrid (0,4l g ; 501%-ige Dispersion, die vor Gebrauch zur Ölentfernung gewaschen wurde) in 25 ml trockenen Di- methylformamide verrührt. Dann wurden 2,5 ml Me- thyliodid hinzugegeben, so dass eine milde exotherme Reaktion stattfand.
Die Mischung wurde 1 Stunde bei 35-4011 C gerührt, dann m-iit :etwa 30 ml Wasser verdünnt und unter vermindertem Druck erwärmt, um das über schüssige Methyliodid abzudampfen. Der vorhandene Feststoff wurde mit Äther herausgelöst, der dann 3 mal mit Wasser gewaschen, an Natriumsulfat getrocknet und zur Trockne eingedampft wurde. Der Rückstand wurde aus Methanol in Gegenwart von Kohle umkristallisiert.
Somit erhielt man farblose Prismen aus Dimethyl-a-(3- (4-chlorphenyl)-2-methoxypyrid-6-yl)-a-methylmalonat, Smp. 106-107 C. <I>Beispiel 2</I> Nach dem Verfahren gemäss Beispiel 1, mit der Abweichung, dass Dimethyl-5-(4-chlorphenyl)pyrid-2-yl- malonat anstelle von Dimethyl-3-(4-chlorphenyl)-2-me- thoxypyrid-6-ylmalonat verwendet wurde, erhielt man Dimethyl-a-(5-(4-chlorphenyl)-pyrid-2-yl)-a-methylmalo- nat. Dieses wurde ber sein Hydrochlorid gereinigt, das aus einer ätherischen Lösung der rohen Base isoliert,
in die Base zurückverwandelt und aus Petroläther (Sdp. 60 80 C) umkristallisiert wurde. Die gereinigte Base hatte einen Schmelzpunkt von 58,5-60 C. <I>Beispiel 3</I> Es wurden 0,247 g Natriumhydrid zu einer Lösung von 1,5 g Dimethyl-4-(4-chlorphenyl)-6-methoxypyrid-2- ylmalonat in 15 ml wasserfreien Dimethylformamids zu gegeben. Die Mischung wurde in einer Stickstoffatmo sphäre gerührt, bis kein Wasserstoff mehr entwickelt wurde und die Auflösung vollendet war. Die klare Lösung wurde dann mit Methyljodid (0,915 g) behandelt und noch 1 Stunde bei Raumtemperatur gerührt. Die gelbe Suspension wurde in 150m1 Wasser eingegossen und 3mal mit Äthylacetat extrahiert.
Die vereinigten organischen Extrakte wurden mit Wasser gewaschen, an Magnesiumsulfat getrocknet und unter vermindertem Druck zu einem gelben Feststoff eingedampft. Der Fest stoff wurde so weit wie möglich in Äther gelöst, und die Mischuni wurde durch eine Kolonne aus Tonerde (Spence-Korngrösse O 30 g) filtriert. Vom Filtrat wurde das Lösungsmittel abgedampft. Somit erhielt man Dimethyl-a-methyl-a-(4-(4-chlorphenyl)-6-methoxypyrid- 2-yl)malonat, Smp. 118-120 C nach Umkristallisierung aus Petroläther (Sdp. 80-100 C).
Claims (1)
- PATENTANSPRUCH Verfahren zur Herstellung von Estern der Formel EMI0002.0019 in welcher X Wasserstoff, einen Alkyl- oder Alkoxyrest mit höchstens 3 C-Atomen oder ein Halogenatom, Y einen gegebenenfalls durch ein oder zwei Halogenatome substituierten Phenylrest, RÚ Wasserstoff, einen Alkyl rest mit höchstens 3 C-Atomen oder einen Alkoxycar- bonylrest mit höchstens 6 C-Atomen und R2 einen Alkyl rest mit höchstens 5 C-Atomen bedeuten, Alk für einen Alkylrest mit höchstens 3 C-Atomen steht und die Reste Y und - C(Alk)RÚ - COORê nicht an benachbarte C- Atome des Pyridinkerns gebunden sind, dadurch gekenn zeichnet,dass man ein Pyridinderivat der Formel EMI0002.0024 oder eine Alkalimetallverbindung davon, in welcher X, Y, RÚ und R2 die obige Bedeutung besitzen und die Reste Y und - C(Alk)RÚ - COORê nicht an benachbarte C-Atome gebunden sind, entsprechend alkyliert. UNTERANSPRÜCHE 1. Verfahren nach Patentanspruch, dadurch gekenn zeichnet, dass die Alkylierung durch Umsetzung eines 1 bis 3 C-Atome enthaltenden Alkylhalogenids mit einer Alkalimetallverbindung des Pyridinderivates durchge- führt wird. 2.Verfahren nach Patentanspruch oder Unteran- spruch 1, dadurch gekennzeichnet, dass die Alkylierung in einem organischen Lösungsmittel durchgeführt wird. 3. Verfahren nach Patentanspruch, dadurch gekenn zeichnet, dass man die Verfahrensprodukte in Salze, insbesondere in .pharmazeutisch zulässige Säureadditions- salze, überführt.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB54135/66A GB1147068A (en) | 1966-12-02 | 1966-12-02 | Phenyl-pyridine derivatives |
| CH1696967A CH492712A (de) | 1966-12-02 | 1967-12-01 | Verfahren zur Herstellung von Pyridinderivaten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH504436A true CH504436A (de) | 1971-03-15 |
Family
ID=25718774
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH343070A CH492714A (de) | 1966-12-02 | 1967-12-01 | Verfahren zur Herstellung von Pyridyl-alkancarbonsäuren |
| CH343170A CH504436A (de) | 1966-12-02 | 1967-12-01 | Verfahren zur Herstellung von Estern |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH343070A CH492714A (de) | 1966-12-02 | 1967-12-01 | Verfahren zur Herstellung von Pyridyl-alkancarbonsäuren |
Country Status (1)
| Country | Link |
|---|---|
| CH (2) | CH492714A (de) |
-
1967
- 1967-12-01 CH CH343070A patent/CH492714A/de not_active IP Right Cessation
- 1967-12-01 CH CH343170A patent/CH504436A/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CH492714A (de) | 1970-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2404113A1 (de) | 4-phenylpiperidine und ihre salze mit pharmazeutisch annehmbaren saeuren, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel | |
| DE1670849B2 (de) | Verfahren zur herstellung von 8-acylamino-1,2,3,4-tetrahydroisochinolinen | |
| AT200578B (de) | Verfahren zur Herstellung von neuen N-Aminoalkylderivaten von Azepinen | |
| DE1935404C3 (de) | Verfahren zur Herstellung von Chinazoline nen | |
| AT202152B (de) | Verfahren zur Herstellung von neuen Dimethylaminopropylidenthiaxanthenen. | |
| CH504436A (de) | Verfahren zur Herstellung von Estern | |
| DD150060A5 (de) | Verfahren zur herstellung von neuen phenthiazin-derivaten | |
| DE2331721A1 (de) | Verfahren zur herstellung neuer heterocyclischer verbindungen | |
| DE936747C (de) | Verfahren zur Herstellung von neuen Pyrimidinderivaten und deren Salzen | |
| CH535767A (de) | Verfahren zur Herstellung neuer N-Phenäthylpiperidinderivate | |
| AT278788B (de) | Verfahren zur herstellung von neuen estern und von deren ssalzen | |
| AT252234B (de) | Verfahren zur Herstellung von neuen Aminoalkyl-substituierten Thiadiazolen | |
| AT259553B (de) | Verfahren zur Herstellung von Indolderivaten | |
| AT278808B (de) | Verfahren zur Herstellung neuer 4-Acyl-3,4-dihydro-2(1H)-chinoxalinonderivate | |
| AT244333B (de) | Verfahren zur Herstellung von neuen Pyrrolderivaten | |
| AT278831B (de) | Verfahren zur herstellung neuer 4-acyl-3,4-dihydro-2(1h)-chinoxalinonderivate | |
| DE2142196C3 (de) | 3- (N- Acyl-indoly I) -essigsäurederivate, Verfahren zu ihrer Herstellung und Arzneipräparate | |
| DE1911893A1 (de) | Verfahren zur Herstellung von N-(Halogen-aryl)-2-methyl-5-alkoxy-indol-3-essigsaeuren | |
| AT211823B (de) | Verfahren zur Herstellung von neuen Aryloxyessigsäureamiden | |
| AT235831B (de) | Verfahren zur Herstellung von neuen Estern basischer Carbinole und ihren Säureadditionssalzen | |
| DE2312256C3 (de) | 5-Pyrazol-essigsäurederivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Mittel | |
| AT278787B (de) | Verfahren zur herstellung von neuen carbonsaeuren und von deren salzen | |
| CH303833A (de) | Verfahren zur Herstellung von Derivaten des Tetrahydro-y-carbolins. | |
| DE2458350A1 (de) | Verfahren zur herstellung von 4-pyridylthioessigsaeureverbindungen | |
| DE1108226B (de) | Verfahren zur Herstellung von hypotensiv wirkenden Phenylpiperazinen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |